Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities (2020 - 2025)

Maravai Lifesciences Holdings has reported Cash from Investing Activities over the past 6 years, most recently at -$2.1 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$2.1 million for Q4 2025, up 57.13% from a year ago — trailing twelve months through Dec 2025 was -$31.4 million (down 29.15% YoY), and the annual figure for FY2025 was -$31.4 million, down 29.15%.
  • Cash from Investing Activities for Q4 2025 was -$2.1 million at Maravai Lifesciences Holdings, up from -$2.9 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for MRVI hit a ceiling of $118.6 million in Q3 2021 and a floor of -$241.6 million in Q1 2022.
  • Median Cash from Investing Activities over the past 5 years was -$5.8 million (2021), compared with a mean of -$17.0 million.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 1275.58% in 2021 and later crashed 8577.59% in 2022.
  • Maravai Lifesciences Holdings' Cash from Investing Activities stood at -$5.7 million in 2021, then crashed by 227.44% to -$18.5 million in 2022, then soared by 30.33% to -$12.9 million in 2023, then soared by 61.78% to -$4.9 million in 2024, then skyrocketed by 57.13% to -$2.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$2.1 million (Q4 2025), -$2.9 million (Q3 2025), and -$3.2 million (Q2 2025) per Business Quant data.